Anson Funds Management LP purchased a new position in Yield10 Bioscience Inc (NASDAQ:YTEN) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 156,482 shares of the specialty chemicals company’s stock, valued at approximately $277,000.

Separately, Renaissance Technologies LLC boosted its position in shares of Yield10 Bioscience by 288.6% in the 4th quarter. Renaissance Technologies LLC now owns 79,576 shares of the specialty chemicals company’s stock worth $141,000 after purchasing an additional 59,100 shares during the last quarter. Hedge funds and other institutional investors own 10.78% of the company’s stock.

Yield10 Bioscience Inc (NASDAQ:YTEN) opened at $1.71 on Wednesday. Yield10 Bioscience Inc has a 12-month low of $1.44 and a 12-month high of $9.30. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a market capitalization of $16.00, a price-to-earnings ratio of -0.53 and a beta of 3.37.

Yield10 Bioscience (NASDAQ:YTEN) last posted its quarterly earnings results on Thursday, March 8th. The specialty chemicals company reported ($0.99) earnings per share (EPS) for the quarter. Yield10 Bioscience had a negative return on equity of 301.80% and a negative net margin of 995.34%. The company had revenue of $0.10 million during the quarter.

ILLEGAL ACTIVITY NOTICE: This report was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at

Yield10 Bioscience Profile

Yield10 Bioscience, Inc, formerly Metabolix, Inc, is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn.

Want to see what other hedge funds are holding YTEN? Visit to get the latest 13F filings and insider trades for Yield10 Bioscience Inc (NASDAQ:YTEN).

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with's FREE daily email newsletter.